THERANOSTIC POLYMERIC NANOMEDICINE
Tumor heterogeneity and adaptive resistance are major challenges in cancer chemotherapy today. In recent years, nanomedicine platforms that integrate imaging sensitivity and therapeutic functions (I.e., theranostic nanomedicine, Figure 1) have received considerable attention as the next generation of medicine. Unlike traditional small molecular contrast agents or drugs, theranostic nanomedicine has the potential to provide simultaneous molecular diagnosis and therapeutic treatment in one system. Such integrated designs allow for the timely tailoring of nanomedicine modules to address the challenges of tumor heterogeneity and adaptive resistance, which can ultimately help achieve the goal of personalized therapy for cancer.
Jinming Gao Xintao Shuai
Department of Pharmacology, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX 75390, USA
国际会议
International Symposium on Polymer Chemistry(第四届国际高分子化学学术研讨会 PC 2010)
苏州
英文
146
2010-06-02(万方平台首次上网日期,不代表论文的发表时间)